# FDA Inspection 1197535 - Central Pennsylvania Blood Bank - February 02, 2023

Source: https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/0e24f6ef-969a-403d-96d2-7b138f9a4f40
Source feed: FDA_Inspections

> FDA Inspection 1197535 for Central Pennsylvania Blood Bank on February 02, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1197535
- Company Name: Central Pennsylvania Blood Bank
- Inspection Date: 2023-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1310476 - 2026-03-11](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/f16dcc23-7197-4fb5-bb41-3f6316f6837a)
- [FDA Inspection 1310476 - 2026-03-11](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/76914058-e970-4b00-9667-5d4feabe88aa)
- [FDA Inspection 1197535 - 2023-02-02](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/a0ca8386-f375-4b88-b539-170d55fba078)
- [FDA Inspection 1072439 - 2018-10-30](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/4c5e1ae3-28e5-4d4c-afd5-63edaa441047)
- [FDA Inspection 905793 - 2014-12-04](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/b608d62e-ca53-4cb6-a7e1-dccae6d53782)

Company: https://www.keypedia.com/companies/central-pennsylvania-blood-bank/e65dd73b-8799-4bc0-8e12-16b5958a628e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d